ACORN CAPITAL ADVISORS, LLC

Q4 2024 13F Holdings

  • Location
    new york, NY
  • Num holdings

    20

  • Value ($000)

    $185,042

  • Date Filed
    02/14/2025
  • Form type
    13F-HR
  • CIK
    0002054410
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
CGON
CGON

CG ONCOLOGY INC

COM
156944100
$32.45M
18 %

1,131,501

YMAB
YMAB

Y-MABS THERAPEUTICS INC

COM
984241109
$22.41M
12 %

2,861,825

CADL
CADL

CANDEL THERAPEUTICS INC

COM
137404109
$16.84M
9 %

1,939,644

---

UROGEN PHARMA LTD

COM
M96088105
$16.15M
9 %

1,516,303

PBYI
PBYI

PUMA BIOTECHNOLOGY INC

COM
74587V107
$12.02M
7 %

2,450,711

---

BICARA THERAPEUTICS

COM
055477103
$11.21M
6 %

643,381

TERN
TERN

TERNS PHARMACEUTICALS INC

COM
880881107
$10.92M
6 %

1,971,264

---

ONKURE THERAPEUTICS INC

CLASS A COM
68277Q105
$10.25M
6 %

1,439,674

---

TREVI THERAPEUTICS INC

COM
89532M101
$8.24M
5 %

2,001,048

TARA
TARA

PROTARA THERAPEUTICS INC

COM STK
74365U107
$6.76M
4 %

1,279,800

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 20